A new method for generating IPS (induced pluripotent stem cells) from a patient’s own mature cells allows for the unlimited production of stem cells and reduces production time from nearly two months to two weeks. Using IPS cells also avoids ethical issues and problems with immune rejection that plague embryonic stem cells.